Advertisement
Screener

Arno Therapeutics, Inc Patents: Applications Pending

Arno Therapeutics, Inc Patent Applications Pending

6 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2017-11-29: Application PCTUS2017063638; Invention METHODS FOR ONAPRISTONE SYNTHESIS DEHYDRATION AND DEPROTECTION; Applicant ARNO THERAPEUTICS, INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
  • 2016-11-30: Application 62428401; Invention METHODS FOR ONAPRISTONE SYNTHESIS DEHYDRATION AND DEPROTECTION; Applicant ARNO THERAPEUTICS, INC.; Status Provisional Application Expired.
  • 2015-11-16: Application PCTUS2015060940; Invention ONAPRISTONE EXTENDED-RELEASE COMPOSITIONS AND METHODS; Applicant ARNO THERAPEUTICS, INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
  • 2015-10-29: Application PCTUS2015057974; Invention ENHANCING THE ANTI-TUMOR, ANTI-VIRAL, AND ANTI-PROTOZOAN EFFECTS OF 2-AMINO-N-[4-[5-PHENANTHREN-2-YL-3-(TRIFLUOROMETHYL)PYRAZOL-1-YL] PHENYL]ACETAMIDE (OSU-03012) AND OTHER PHARMACEUTICAL DRUGS; Applicant ARNO THERAPEUTICS, INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2017-11-29PCTUS2017063638METHODS FOR ONAPRISTONE SYNTHESIS DEHYDRATION AND DEPROTECTIONARNO THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
ULF TILSTAM
FERRY BRANDS
STEFAN PRONIUK
Belgium
Netherlands
United States
2016-11-3062428401METHODS FOR ONAPRISTONE SYNTHESIS DEHYDRATION AND DEPROTECTIONARNO THERAPEUTICS, INC.Provisional Application Expired
Ulf Tilstam
Stefan Proniuk
Ferry Brands
Belgium
United States
Netherlands
2015-11-16PCTUS2015060940ONAPRISTONE EXTENDED-RELEASE COMPOSITIONS AND METHODSARNO THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
STEFAN PRONIUK
ALEXANDER ZUKIWSKI
United States
United States
THOMAS, SHANE M
2015-10-29PCTUS2015057974ENHANCING THE ANTI-TUMOR, ANTI-VIRAL, AND ANTI-PROTOZOAN EFFECTS OF 2-AMINO-N-[4-[5-PHENANTHREN-2-YL-3-(TRIFLUOROMETHYL)PYRAZOL-1-YL] PHENYL]ACETAMIDE (OSU-03012) AND OTHER PHARMACEUTICAL DRUGSARNO THERAPEUTICS, INC.
VIRGINIA COMMONWEALTH UNIVERSITY
RO PROCESSING COMPLETED-PLACED IN STORAGE
STEFAN PRONIUK
ALEXANDER ZUKIWSKI
PAUL DENT
United States
United States
United States
2011-05-11PCTUS2011036079COMPOSITIONS AND METHODS FOR REDUCING PROLIFERATION AND VIABILITY OF LYMPHOBLASTOID CELLSARNO THERAPEUTICS, INCRO PROCESSING COMPLETED-PLACED IN STORAGE
ROBERT A. BAIOCCHI
United States
YOUNG, LEE W
2011-02-22PCTUS2011025702METHODS AND COMOSITIONS FOR INHIBITING AND PREVENTING THE GROWTH OF MALIGNANT MAST CELLSARNO THERAPEUTICS, INCRO PROCESSING COMPLETED-PLACED IN STORAGE
CHERYL A. LONDON
SAMUEL KULP
TZU-YIN LIN
United States
United States
United States
YOUNG, LEE W